JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hadithi, M.
Right arrow Articles by Comans, E. F.I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hadithi, M.
Right arrow Articles by Comans, E. F.I.
Journal of Nuclear Medicine Vol. 47 No. 10 1622-1627
© 2006 by Society of Nuclear Medicine


Clinical Investigation

18F-FDG PET Versus CT for the Detection of Enteropathy-Associated T-Cell Lymphoma in Refractory Celiac Disease

Muhammed Hadithi1, Maarten Mallant2, Joost Oudejans3, Jan-Hein T.M. van Waesberghe2, Chris J. Mulder1 and Emile F.I. Comans4

1 Department of Gastroenterology, VU University Medical Center, Amsterdam, The Netherlands; 2 Department of Radiology, VU University Medical Center, Amsterdam, The Netherlands; 3 Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands; and 4 Department of Nuclear Medicine and PET Research, VU University Medical Center, Amsterdam, The Netherlands

Correspondence: For correspondence or reprints contact: Muhammed Hadithi, MD, Department of Gastroenterology, Vrije Universiteit Medical Center, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands. E-mail: m.hadithi{at}vumc.nl

Refractory celiac disease (RCD) can evolve into enteropathy-associated T-cell lymphoma (EATL). 18F-FDG PET has been reported to discriminate between RCD and EATL. Because prospective data are lacking, we designed a prospective study to evaluate the potential of 18F-FDG PET for detection of EATL in patients with RCD and compared the results with those obtained using abdominal CT in a referral center. Methods: Between April 2003 and April 2005, 8 consecutive patients (median age, 66 y; range, 52–89 y) with EATL and 30 patients (median age, 61 y; range, 44–71 y) with RCD were included. CT and 18F-FDG PET were performed on all patients. Histologic evidence of EATL was identified in tissue samples obtained during upper gastrointestinal endoscopy or surgical resection. Results: Villous atrophy was found in all patients with RCD and all (except 1) patients with EATL in nontumoral mucosa. Histologic examination of 1 patient with EATL localized in the duodenum showed intraepithelial lymphocytosis only. 18F-FDG PET could reveal sites histologically proven to be EATL in all 8 patients, whereas CT showed normal findings in 1 patient with EATL. 18F-FDG PET detected unsuspected extraintestinal sites affected by EATL in 2 patients. CT showed abnormalities such as a thickened small-bowel wall or lymphadenopathy in 14 patients with RCD lacking evidence of EATL at follow-up. 18F-FDG PET findings were positive in 3 and equivocal in another 3 patients with RCD. 18F-FDG PET was more sensitive and specific than CT (100% vs. 87% and 90% vs. 53%, respectively). Conclusion: Our data show that 18F-FDG PET is more sensitive in detecting EATL in patients with RCD than is CT. 18F-FDG PET, in addition to conventional CT, is recommended for evaluating patients with RCD.

Key Words: refractory celiac disease • enteropathy-associated T-cell lymphoma • computed tomography • positron emission tomography


Related articles in JNM:

This Month in JNM

JNM 2006 47: 9a-10a. [Full Text]  



This article has been cited by other articles:


Home page
GutHome page
A Al-toma, W H M Verbeek, M Hadithi, B M E von Blomberg, and C J J Mulder
Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience
Gut, October 1, 2007; 56(10): 1373 - 1378.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2006 by the Society of Nuclear Medicine.